Optimize inventory to reduce cost, increase customer satisfaction, and improve care for everyone in the healthcare space
Yearly revenue for medical devices is expected to surpass $580 billion by 2027 as industry advancements and demand continues to grow. Despite this growth, it’s no longer viable to merely manufacture and distribute medical devices without careful consideration into the who, what, where, when, and why relative to the end user—considering supply chain management constitutes the second largest healthcare expenditure.
Between downward pricing pressures as payers look to reduce costs, a purchasing shift from clinical to economic buyers, and an ever-changing regulatory landscape, medical device manufacturers must now evaluate their distribution network to ensure proper placement and production levels to balance patient care against optimal inventory positioning.
Addressing these challenges is nuanced. To ensure high quality patient care, a medical device must move through warehouses, sales reps’ trunks, and hospital closets—and each of these locations has its own practices, policies, and systems. Discrepancies and inefficiencies in and around all these points have significant downstream effects—higher cost of goods and an overall decrease in quality of care, all stemming from a lack of proper inventory management.
To address all these factors—reducing costs, increasing customer satisfaction, improving care—while maximizing market opportunity, medical device manufacturers must prioritize inventory optimization tactics.
In what follows, we’ll explore the challenges of adopting inventory optimization for medical device manufacturing, how these challenges impact each healthcare player from patient to payers, and explore solutions that reduce cost and improve patient care.
Inventory optimization is critical—but there are a number of factors that can inhibit that reality:
Supply chain management, already constituting the second largest pool of expenditure in healthcare, becomes even more costly with mismanaged inventory.
Increased lead times result in delays in care. Any time cost is not contained, it may negatively impact care delivery due to inefficient and ineffective use of resources, resulting in poorer patient experience. Increases in cost and time of care result in a less equitable and efficient healthcare system—the impacts of which are felt most acutely by the most vulnerable patient populations.
Inventory-associated losses are accepted as the cost—often the largest—of business for manufacturers. But it doesn’t have to be this way; efficiencies in inventory management can provide robust positive impacts to manufacturer’s bottom line and to the operations and experiences of those organizations and individuals who depend on medical devices. Realizing these impacts involves managing third parties, adhering to regulations, and always placing care delivery as the top priority.
Between sales representatives, healthcare providers, and manufacturers, a multitude of systems exist. From this, dissonance arises about what inventory is where and in what condition, preventing proper inventory management and leading to waste through shrink and obsolescence. Inventory data is also often lacking or nonexistent. For a fix, manufacturers must digitize and integrate these disparate systems to provide a single source of truth that leverages inventory data. Doing so can be as simple as providing sales representatives with comprehensive field management solutions and labeling medical devices with QR codes that are connected to your ERP for use by medical professionals.
Demand for medical devices is anything but predictable, and existing inventory visibility issues complicate an already difficult problem; demand planning. But with advancements in artificial intelligence and machine learning, demand sensing offers a proactive, real-time method to identify demand and react accordingly, like RFID. For medical device manufacturers, this will allow for less field inventory and tighter JIT windows.
By developing a multi-pillar, stakeholder visibility solution to manage inventory, manufacturers may make more informed decisions by leveraging data. Using an incentive model and metrics that prove the value of inventory optimization to all stakeholders, manufactures can show the benefit of proper inventory management for all parties and gain cross-functional buy-in from hospital administrators and clinicians.
A consistent challenge in dealing with medical devices is ensuring that any action taken does not interfere with patient care, a consideration that is at the heart of many medical device inventory issues. As a result, medical devices are everywhere to ensure low to no lead times. However, in doing so medical devices are in places where they do not have to be, creating additional costs and waste. To resolve this, utilize network analysis to identify demand of a given product nearest its point of consumption to match inventory needs to demand impulses and transportation constraints.
While proper inventory management of medical devices is a delicate balance requiring focused attention and concerted efforts, using core supply chain principles and new technologies can alleviate what has for too long been accepted as the norm. Improving the efficiency and cost-effectiveness of the healthcare system is the responsibility of each healthcare player, and inventory optimization is an important aspect of that system’s effective functioning.
Medical device manufacturers are in position to not only help their businesses thrive but to make meaningful improvements to the overall healthcare system. Achieving this comes down to integrating systems to provide a single source of truth, leveraging demand sensing to enable better predictability, increasing visibility and encouraging better decision-making with metrics and incentives, and ensuring lower lead times.
Adopting Digital Mindsets: Where Healthcare Stakeholders Are Succeeding and Where They’re Falling Short
Rising to the Occasion: What Patient Centricity Means in Life Sciences and How to Achieve It
Your organization’s siloed structure is inhibiting your digital future
How using data analytics in private equity can better inform portfolio strategies in a downturn